⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DRMA News
Dermata Therapeutics, Inc. Common Stock
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
accessnewswire.com
DRMA
Form 8-K
sec.gov
DRMAW
DRMA
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
accessnewswire.com
DRMA
Form 8-K
sec.gov
DRMAW
DRMA
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
accessnewswire.com
DRMA
Form 8-K
sec.gov
DRMA
DRMAW
Form 8-K
sec.gov
DRMA
DRMAW
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
accessnewswire.com
DRMA
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
accessnewswire.com
DRMA
DRMAW
Form 8-K
sec.gov
DRMAW
DRMA